The Development of Malignant Tumours of Mouse Skin after “Initiating” and “Promoting” Stimuli. I. The Effect of a Single Application of 9, 10-Dimethyl-1, 2-Benzanthracene (DMBA), with and without Subsequent Treatment with Croton Oil by Roe, F. J. C.
61
THE DEVELOPMENT OF MALIGNANT TUMOURS OF MOUSE SKIN
AFTER " INITIATING " AND " PROMOTING " STIMULI
I. THE EFFECT OF A SINGLE APPLICATION OF 9,10-
DIMETHYL-1,2-BENZANTHRACENE (DMBA), WITH AND
WITHOUT SUBSEQUENT TREATMENT WITH CROTON OIL
F. J. C. ROE
From the Cancer Research Department, London Hospital Medical College. London, E.1
Received for publication January 19, 1956
MucH experimental work has been reported which supports the view that
carcinogenesis is divisible into stages. For two of these the terms " initiation "
and " promotion ", proposed by Friedewald and Rous (1944), have superseded
others (for reviews of previous work, and terminologies, see Berenblum, 1944;
Rusch, 1944; and Foulds, 1954).
In the past decade many workers in this field have reported the induction of
skin tumours in mice by treatment with a single application of a carcinogenic
agent (the initiating stimulus) followed by a limited course of croton oil treatment
(the promoting stimulus). (Mottram, 1944a, 1944b, 1945; Rusch and Kline,
1946; Berenblum and Shubik, 1947a, 1947b, 1949; Bielschowsky and Bullough,
1949; Salaman and Gwynn, 1951; Salaman and Roe, 1953; Berenblum and
Haran, 1955). In some of these experiments control mice were given treatment
with an initiating dose of the carcinogen alone. Mice so treated developed few
or no tumours during a period of observation limited, as a rule, to some 20 to 30
weeks. In other experiments no such control group was included. Similarly, in
experiments where control mice were given treatment with croton oil alone for a
limited period, few or no tumours developed; but again in several cases this
control was omitted.
It is, however, well established that skin tumours may arise after a single
application of a carcinogenic agent (Findlay, 1925; Mider and Morton, 1939;
Law, 1941; Cramer and Stowell, 1943; Bielschowsky and Bullough, 1949),
though usually only after a long latent interval (Findlay, 1925). But it has never
been established what proportion of tumours, benign or malignant, appearing in
mouse skin after initiating and promoting stimuli would have arisen in the
absence of the latter.
Another phenomenon which has been insufficiently considered in work on
initiation and promotion is that of regression of tumours. There is no doubt that
of the tumours which appear on mouse skin after a single application of
9,10-dimethyl-1,2-benzanthracene (DMBA) followed by a limited course of croton
oil treatment, a considerable proportion regress (Shubik, 1950). Similar findings
were reported for the rabbit's ear, after various initiating and promoting stimuli,
by Rous and his colleagues (Rous and Kidd, 1939, 1941; Mackenzie and Rous,
1941; Friedewald and Rous, 1944).
In this series offour papers the roles of initiator and promoter in the induction62 F. J. C. ROE
ofbenign and malignant tumours of mouse skin will be reconsidered, using DMBA
as the initiating agent and croton oil as the promoting agent.
In the present paper an attempt is made to answer the question whether a
limited course of croton oil treatment increases the final incidence of benign and
malignant tumours which follow a single application ofDMBA, when observation
is prolonged till death.
MATERIALS AND METHODS
]lHice.-Stock albino male mice ofthe " S " strain (Salaman and Gwynn, 1951;
Salaman and Roe, 1953'; Roe and Salaman, 1954, 1955) were used throughout.
They were fed on cubes prepared according to the Rowett Institute formula
(Thomson, 1930a, 1930b), plus fresh greenstuff twice a week and water ad libitum.
Before the experiment was begun mice were vaccinated on the tail with sheep
lymph as a precaution against ectromelia: only positive reactors were used.
The age of mice at the beginning of the experiments was between 7 and 9
weeks.
Chemical agents and solvents.-9,10-Dimethyl-1,2-benzanthracene (J)MBA)
was obtained from Messrs. L. Light and Co.
The croton oil used was ofthe same batch used in previous experiments in this
laboratory (Salaman and Gwynn, 1951 ; Salaman and Roe, 1953; Roe and
Salaman, 1954, 1955). In the third paper of this series (Roe, 1956) it is referred
to asBatch I. It waspreparedfromthe seeds ofCrotontigliumbysimple expression,
by Messrs. Stafford Allen and Sons, Ltd., 20 Wharf Road, London, N.1.
Acetone was the solvent both for DMBA and croton oil.
Techniqueofapplication.-The hair ofthe whole backfrom forelimbs to tail was
clipped at the beginning of the experiment and subsequently when necessary.
The solutions were delivered from calibrated pipettes, care being taken that they
spread as evenly as possible over the clipped area. 0-2 ml. of the DMBA solution,
and 0 3 ml. of the croton oil solution, were applied.
Histological examination.-Biopsy specimens and tissues taken for section
during post mortem examination were fixed in Zenker's fluid, embeddedinparaffin
wax, and stained with haematoxylin and eosin-Biebrich scarlet (Salaman and
Gwynn, 1951).
EXPERIMENTAL
Five groups of male mice were used in the experiment. The groups were
derived from two batches: A and B. Batch B was received from the animal-
breeder approximately three months after Batch A. The age of mice at the
beginning of treatment was always between 7 and 9 weeks. Table I shows from
TABLE I.-Treatment of Groups.
Batch of Number Secondary
Group. mice. of mice. Primary treatment. Interval. treatment.
1 . A . 30 . Single application of . . None
0-2 ml. 0-15 per cent
DMBA in acetone
2 . A . 20 . Ditto .
3 . B . 10 . .. .
4 . A . 20 . . 4 weeks . 18 weekly applica-
tions of 0 3 ml.
0 5 per cent cro-
ton oil in acetone
5 . B . 10 . . . DittoDEVELOPMENT OF TUMOURS OF MOUSE SKIN
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which batch mice of the different groups were derived, and the number of mice in
each group.
After successful vaccination on the tails with sheep lymph, and removal of
hair from the backs by clipping, all the mice were given a single application of
0u2 ml. 0o15 per cent DMBA in acetone. Groups 1, 2, and 3 received no further
treatment. Groups 4 and 5 began a course of 18 weekly applications of 0-3 ml.
05 per cent croton oil in acetone 4 weeks after the application of DMBA.
During the course ofcroton oil treatmentmice in Groups 4and 5 were examined
weekly for papillomata; after the end of treatment weekly examination was
continued, but only malignant tumours were recorded. Mice ofGroups 1, 2, and 3
were examined weekly throughout the experiment for the presence of malignant
tumours. When a mouse died, or was killed, a record was made of all benign and
malignant skin tumours, including any outside the treated area. Occasionally,
because the death ofa mouse wentunnoticed, skintumours were rendered uncount-
able by advanced post-mortem changes. Such mice were few, and were omitted
from the results recorded in Tables II and III.
If, at the weekly inspection, a mouse was thought to have a malignant tumour
of the skin, it was set aside for more frequent observation. When the naked-eye
appearance of a tumour left no doubt that it was malignant, and it appeared
operable, an attempt was made to remove it by biopsy under ether anaesthesia.
The naked-eye assessment of malignancy was based on the following character-
istics: ulceration, haemorrhage, an undermined edge, rapid expansion between
successive observations, adherence to deep structures, and enlargement of the
regional lymph node. Successful operative removal of such tumours made it
possible for individual mice to develop multiple malignant tumours in sequence.
Careful note was made of the position of scars, lest a local recurrence should be
mistaken for a second malignant tumour.
All apparently malignant, and many apparently benign, tumours were taken
for histological examination. In addition regional lymph glands were taken for
section from mice bearing (or which had borne before operative removal)
apparently malignant tumours.
EXPLANATION OF PLATES
FIG. 1.-Carcinoma below the right eye of a mouse 48 weeks after a single application of
9,10-dimethyl-1,2-benzanthracene (DMBA) to the skin of the back. There were also 2
papillomata in the submandibular region: one of these can be seen in the photograph.
x 3.
FIG. 2.-Section of tumour shown in Fig. 1. Masses of carcinoma cells have infiltrated the
subcutaneous tissues, and in one place have surrounded a nerve deep to a facial muscle.
On the right is the large follicle of a vibrissa. x 20.
FIG. 3 and 4.-Medium-power views oftwo areas in Fig. 2. Fig. 3 shows carcinomatous masses
containing a few horny pearls; and Fig. 4, a nerve surrounded by a mass of carcinoma
cells deep to facial muscle. x 50.
FIG. 5.-" Probably malignant " tumour (see text, p. 66) below the left eye of a mouse 48
weeks after a single application of DMBA to the skin of the back (Group 1). Note the
proximity of this tumour to the follicles of the vibrissae. x 3.
FIG. 6.-Section ofa tumour in amouse which had received one application ofDMBA, followed
by I8 weekly applications of croton oil. This tumour appeared malignant when first seen,
41 weeks after the beginning of treatment. A carcinomatous mass is seen infiltrating the
panmiculus carnosus. x 20.
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RESITLTS
(a) The incidence ofpapillornata.
In Groups 4 and 5 papillomata began to appear on the backs 8 weeks after
the beginning of croton oil treatment, and increased in total number until the
end of treatment, though the weekly records indicate quite clearly that some
tumours disappeared during this period. Thereafter the total number of papil-
lomata on the backs gradually declined, though, as noted by Salaman (1952), a
few new ones appeared.
In Groups 1, 2, and 3 papillomata began to appear during the 30th week ofthe
experiment. Most of these tumours were situated on the face or head, and only
few on other sites (backs, bellies, and limbs). The cheeks near the follicles of the
vibrissae, the lips, the eyelids, the ears, and the mandibular region were the most
commonly affected sites. Not all these tumours persisted until death. Throughout
the period ofobservation tumours ofsites other than the back were more numerous
in Groups 1, 2, and 3 than in Groups 4 and 5.
Table II shows the numbers ofpapilloma-bearing mice, and the mean numbers
of tumours per surviving mouse, at the end of croton oil treatment and at death.
Standarddeviations aboutthe means are alsogiven. The mean numbers oftumours
on the backs of mice of Groups 4 and 5 at the time of death (i.e. about 60 weeks
after the beginning of treatment) were between one-third and one-half the corre-
sponding values at the end of croton oil treatment. In other words, between one-
half and two-thirds of the papillomata originally present had disappeared. It
will be noted that this regression of tumours after the end of treatment occurred
in mice of both batches, A and B.
The mean number of papillomata per mouse at the end of croton oil treatment in
Groups 4 and 5 exceeded that attained at any time by mice ofGroups 1, 2, and 3;
but the difference was significant only when tumours on the treated areas alone
were considered.
The mean numbers ofpapillomata ofall sites at death did not differ significantly
between groups which had received croton oil treatment and those which had not.
In considering the relation of these results to those of Berenblum and Shubik,
it is necessary to bear in mind that the effect on papilloma-incidence ofsubsequent
croton oil applications in mice treated with a single application of DMBA is
clearly dependent on the time at which the observations are made. After the end
of croton oil treatment the numbers of papillomata in Groups 4 and 5 gradually
declined, but those in Groups 1, 2, and 3, which received no croton oil, gradually
rose during the corresponding period. It would have been possible, by killing the
mice after an arbitrary period shorter than the average life-span, to show an
apparent positive influence of croton oil on papilloma-incidence at death similar
to that observed by Berenblum and Shubik. Conversely, if the mice had lived
longer than they did, and the observed trends had continued, croton oil treatment
might have appeared to have had a negative influence. Under the actual con-
ditions of this experiment, however, the most clearly marked difference at the
time of death between mice treated with DMBA alone and those treated with
DMBA followed by croton oil was not in the incidence of papillomata but in
their site: in mice treated with DMBA alone the majority of papillomata were
on the faces and heads, whereas in those treated with DMBA and croton oil
almost all the tumours were situated on the backs. Mice of both batches (A
and B) showed this difference in site oftumours at death.
5
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(b) Incidence of malignant tumour8
The histological criterion of malignancy for tumours on the back was infiltra-
tion of the continuous layer of muscle situated on the deep surface of the dermis,
namely, the panniculus carno8u8. For tumours on the face, infiltration of the
facial muscles was the criterion. A few tumiours showed other indications of
malignancy (e.g. ulceration, anaplasia, and infiltration of the dermal collagen),
but failed to fulfil the chosen criterion ; these were called " probably malignant ".
Table III shows the numbers of mice bearing malignant tumours, and the
numbers, sites, and mean time ofappearance, ofmalignant tumours in the different
groups. The first malignant tumour to appear was in a mouse of Group 4 during
the 36th week after treatment with DMBA. In all groups mice which died or were
killed before the 36th week were excluded from the table. As stated above, a few
mice couldnot beexamined satisfactorily fortumours at deathbecause ofadvanced
post-mortem changes; these mice were also excluded. Thetime ofappearance ofa
malignant tumour was arrived at retrospectively: when a tumour was found to
be malignant on histological examination the weekly records immediately prior
to the date of biopsy or death were consulted, and the date when the tumour was
first thought to be malignant on naked-eye examination was taken to be its time
of appearance. The incidence and sites of " probably malignant " tumours in the
different groups is shown in the last column of the Table.
Among the 47 survivors of Groups 1, 2, and 3 (DMBA only), 6 bore malignant
and 4 " probably malignant " tumours. No mouse bore more than one such
tumour, nine ofwhich were on the face or head; the remaining tumour, a " prob-
ably malignant" one, was in the scapular region. The mean latent interval
between treatment with DMBA and the appearance of the definitely malignant
tumours was 55-3 weeks with a standard deviation of ± 4*7 weeks. Fig. 1-4 show
one of the malignant tumours of the face as it appeared to the naked eye and
microscopically. Fig. 5shows thenaked-eye appearance ofa "probably malignant"
tumour of the face.
Among the 21 survivors of Groups 4 and 5 (DMBA followed by croton oil), 13
malignant tumours appeared on the back and 1 on the face. There were no
"probablymalignant "tumours inthesegroups. Altogether 8 miceboremalignant
tumours; 1 bore 3 tumours, 4 bore 2 tumours, and 3 bore one tumour each. The
mouse with the facial tumour had no other malignant tumours. The mean latent
interval between treatment with DMBA and the appearance ofmalignant tumours
on the back was 46-3 weeks with a standard deviation of ± 2-5 weeks. The facial
tumour appeared after an interval of 53 weeks.
All the malignant tumours were of epithelial origin. All grades from well-
differentiated squamous-cell carcinomata to highly anaplastic tumours were
encountered.
Of the mice bearing definitely malignant tumours in Groups 1, 2, and 3, two
had metastases in the lymph glands of the neck. One of the mice in Group 4,
and 1 in Group 5, bearing malignant tumours on the back, had metastases in the
regional (i.e. axillary or inguinal) lymph glands. No metastases at more distant
sites were found.
There was evidence, either from the preceding weekly records, or from the
hiistological appearance, that the majority of malignant tumours arose in pre-
existing papillomata. A few, however, appeared malignant from the time they
were first seen. Fig. 6 shows a section of such a tumour.
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(c) Relation between incidence ofpapillomata and carcinonata
The results suggested that there was a relation between the site of occurrence
of papillomata and carcinomata. Groups 1, 2, and 3, which had most papillomata
on the face or head at death, also had most carcinomata on this site. Similarly,
Groups 4 and 5, which had most papillomata onthe backs, alsohad most malignant
tumours on this site.
The correlation coefficient (r) between the number of papillomata and the
number of carcinomata, on individual mice, was calculated (Snedecor, 1946, p.
138). Values ofr between 0 and + 1*0 indicate a positive correlation between the
variates, and values between 0 and - 1 0 a negative correlation. When r is zero
the two variates are uncorrelated. The probability (P) that a correlation between
the two variates, at least as big as the observed value, would have occurred by
chance is given in tables for r under the heading of the appropriate number of
degrees of freedom (n - 2, where n is the number of mice).
Firstly a correlation table was prepared for mice ofGroups 1, 2, and 3. In this
case the two variates were the number of benign tumours, and the number of
malignant tumours, onthefaceand headofindividualmiceatdeath. Thecalculated
value for r in this test was + 0 09 on 45 degrees offreedom. This slightly positive
correlation between the two variates did not reach the customary 5 per cent level
of significance.
In a second test the two variates were the number of papillomata on the backs
of individual mice of Groups 4 and 5, at the end of croton oil treatment, and the
number ofdefinitely malignant tumours which subsequently arose on the backs of
the same mice. The calculated value for r was + 0 57 on 19 degrees of freedom,
and the probability (P) that this positive correlation would have occurred by
chance was less than 1 per cent.
A final test was made for correlation between the number of papillomata on
individual mice of Groups 4 and 5 at death, and the total number of malignant
tumours on the same mice. Again, a significantly positive correlation was found
(r = + 0-465 on 19 degrees of freedom, 0-01 < P < 0 05).
An observation reported by Shubik (1950) is relevant at this point: he stated
that when a mouse developed a malignant tumour ofthe skin, many of its benign
tumours regressed. In the present series (Groups 4 and 5) the regression rate of
papillomatafollowing the end ofcroton oil treatment was not significantly different
in mice which developed malignant tumours and in those which did not, namely 56
per cent in the former and 57-5 per cent in the latter. The numbers of animals in
this series was small for such a comparison, but in a similar and much larger series
(to be described in a later paper, Salaman and Roe, 1956) the papilloma-regression
rate was actually higher in mice without malignant tumours than in those with
them, namely 17 per cent and 10 per cent, respectively. (The period between the
end of treatment and death was considerably shorter in this case.) There was
virtually no difference in the average survival-time between the two classes in
either of these series.
CONCLUSIONS
After a single application of0-2 ml. 0X15 per cent DMBA to the backs ofmice of
the " S " strain, there appeared many benign and a few malignant tumours. The
inajority of the benign, and all the malignant, tumours arose from the skin of the
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face and head, i.e. outside the treated area. The first benign tumour appeared 30
weeks after the application of DMBA, and the first malignant tumour some 15
weeks later. Spontaneous tumours of the skin are a rarity in untreated ' S"
strain mice (unpublished data), and it is reasonable to conclude that the tumours
were the result of the treatment.
A course of 18 weekly applications ofcroton oil following a single application of
DMBAevoked the formation of numerous papillomata on the backs of mice, from
the 8th week onwards, but between one half and two thirds of these tunmours
disappeared during the 30- to 40-week period which elapsed between the end of
croton oil treatment and death. Only one papilloma appeared outside the treated
area in these mice. The total number of papillomata of all sites at death was little
affected by the administration ofcroton oil: a higher incidence oftumours on the
treated areas in croton oil-treated mice being almost completely offset by a higher
incidence oftumours outside the treated areas in mice which received no croton oil.
In other words, application of croton oil determined the site, and accelerated the
appearance, of papillomata following a single application of DMBA; but because
of the late appearance of papillomata in mice treated with DMBA only, and
their regression after the end of treatment in those which received croton oil after
DMBA, there was no significant difference in the numbers of papillomata of all
sites at death between groups which received croton oil and those which did not.
If the experiment had been terminated earlier the mice treated with croton oil
after DMBA would have apparently had a higher incidence of papillomata than
those treated with DMBA only. Such a result would have been in keeping with
that of Berenblum and Shubik (1947a).
Administration of croton oil determined the site and time of appearance of
malignant tumours following treatment with DMBA, and in addition increased
the incidence of mice bearing these tumours from 13 to 38 per cent. The fact that
benign tumours may regress but malignant tumours do not is perhaps responsible
for the latter effect.
Those mice in Groups 4 and 5 which had the most papillomata at the time
croton oil treatment was stopped subsequently developed significantly more
malignant tumours than those which had few or no papillomata at that time.
There is thus a positive correlation between the incidence ofbenign and malignant
tumours in individual mice.
These results will be further discussed in another communication (Salaman and
Roe, 1956).
SUMMARY
1. Mice treated with a single application of 0-15 per cent 9,10-dimethyl-1,2-
benzanthracene (DMBA) to the skin ofthe back followed by a course of 18 weekly
applications of 0-5 per cent croton oil were observed till death.
One week after the end of croton oil treatment many papillomata were present
on the treated areas. Thereafter 14 malignant tumours appeared, 13 on the treated
areas and one on the face; most of these developed in pre-existing papillomata.
Over a half of the papillomata disappeared before death.
There was a significant positive correlation in individual mice between the
number of papillomata at the end of croton oil treatment and the number of
malignant tumours which subsequently appeared.
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'. In mice which received a single application of DMBA without subsequent
treatment papillomata began to appear at the 30th week, and increased in number
till death. Less than half these tumours were on the treated areas; most of the
rest were on the face and head. Six malignant and 4 probably malignant tumours
appeared: all were on the face or head, except for one " probably malignant"
tumour which was on the treated area.
3. Discussion of these results is deferred to a subsequent communication.
The author gratefully acknowledges his debt to Miss 0. M. Glendenning, Mr.
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